Food allergy and anaphylaxis in pediatrics: update 2010-2012

Alexandra F Santos1, Gideon Lack

  • 1Department of Pediatric Allergy, Division of Asthma, Allergy & Lung Biology, King's College London, MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK. alexandra.santos@kcl.ac.uk

Insights

This review covers pediatric food allergy (FA) and anaphylaxis research since 2010. Advances in diagnosis, oral immunotherapy, and dietary management offer improved quality of life for allergic children.

Area of Science:

  • Pediatric Allergy and Immunology
  • Food Allergy Research
  • Anaphylaxis

Background:

  • Food allergy (FA) and anaphylaxis are significant concerns in pediatric health.
  • Research since 2010 has elucidated potential risk factors and improved diagnostic approaches.

Purpose of the Study:

  • To review advancements in pediatric food allergy and anaphylaxis research published since 2010.
  • To highlight progress in diagnosis, treatment, and management strategies.

Main Methods:

  • Literature review of studies published in Pediatric Allergy and Immunology from 2010 onwards.
  • Analysis of research on risk factors, diagnostics, oral immunotherapy, and nutritional aspects of FA.

Main Results:

  • Identified risk factors include family history, birth order, season of birth, and atopic eczema.
  • Oral food challenges are the gold standard for diagnosis; oral immunotherapy shows promise for improving quality of life.
  • Nutritional deficiencies are common and require assessment; adrenaline prescription needs improvement.

Conclusions:

  • Continued research into FA epidemiology and immunology is crucial for developing effective prevention and treatment strategies.
  • Improved training and guideline implementation are needed for anaphylaxis management.
  • Dietary broadening and oral immunotherapy can reduce the psychological impact of FA.

Related Concept Videos

Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Allergic Reactions02:06

Allergic Reactions

Overview
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...